These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12529798)

  • 21. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-induced failure of botulinum toxin type B therapy in de novo patients.
    Dressler D; Bigalke H
    Eur Neurol; 2004; 52(3):132-5. PubMed ID: 15479980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anhidrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentrations.
    Rystedt A; Swartling C; Naver H
    Acta Derm Venereol; 2008; 88(3):229-33. PubMed ID: 18480920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of therapeutic botulinum toxin preparations.
    Dressler D; Benecke R
    Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological aspects of therapeutic botulinum toxin preparations].
    Dressler D
    Nervenarzt; 2006 Aug; 77(8):912-21. PubMed ID: 16810528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Initial experiences with clinical use of botulinum toxin type B].
    Dressler D; Benecke R
    Nervenarzt; 2002 Feb; 73(2):194-8. PubMed ID: 11975099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
    Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
    Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
    [No Abstract]   [Full Text] [Related]  

  • 28. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
    Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K
    Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
    Kreyden OP; Scheidegger EP
    Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc.
    Dressler D; Hallett M
    Eur J Neurol; 2006 Feb; 13 Suppl 1():11-5. PubMed ID: 16417592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study.
    Hecht MJ; Birklein F; Winterholler M
    Arch Dermatol Res; 2004 Feb; 295(8-9):318-9. PubMed ID: 14648075
    [No Abstract]   [Full Text] [Related]  

  • 33. What stands in the way of treating palmar hyperhidrosis as effectively as axillary hyperhidrosis with botulinum toxin type A.
    Benohanian A
    Dermatol Online J; 2009 Apr; 15(4):12. PubMed ID: 19450405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A.
    Saber M; Brassard D; Benohanian A
    Arch Dermatol; 2011 May; 147(5):629-30. PubMed ID: 21576592
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis.
    Ito K; Yanagishita T; Ohshima Y; Tamada Y; Watanabe D
    J Dermatol; 2011 Sep; 38(9):859-63. PubMed ID: 21545498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections.
    Dubow J; Kim A; Leikin J; Cumpston K; Bryant S; Rezak M
    Mov Disord; 2005 Jul; 20(7):877-80. PubMed ID: 15806568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
    Blitzer A
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
    Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B
    Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients.
    Doft MA; Kasten JL; Ascherman JA
    Aesthetic Plast Surg; 2011 Dec; 35(6):1079-86. PubMed ID: 21559989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
    Krogstad AL; Skymne A; Pegenius G; Elam M; Wallin BG
    Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.